Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment-Resistant Depression Revisited: A Glimmer of Hope
Angelos Halaris, Emilie Sohl, Elizabeth A. Whitham
Journal of Personalized Medicine (2021) Vol. 11, Iss. 2, pp. 155-155
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Dietary Nutrient Deficiencies and Risk of Depression (Review Article 2018–2023)
Magdalena Zielińska, Edyta Łuszczki, Katarzyna Dereń
Nutrients (2023) Vol. 15, Iss. 11, pp. 2433-2433
Open Access | Times Cited: 44
The relationship between nutrition and depression in the life process: A mini-review
Gülseren Nur Ekinci, Nevin Şanlıer
Experimental Gerontology (2022) Vol. 172, pp. 112072-112072
Open Access | Times Cited: 57
The Power of Psychobiotics in Depression: A Modern Approach through the Microbiota–Gut–Brain Axis: A Literature Review
Angela Dziedzic, Karina Maciak, Katarzyna Bliźniewska-Kowalska, et al.
Nutrients (2024) Vol. 16, Iss. 7, pp. 1054-1054
Open Access | Times Cited: 13
Abnormal expression profile of plasma-derived exosomal microRNAs in patients with treatment-resistant depression
Liandi Li, Muhammad Naveed, Ziwei Du, et al.
Human Genomics (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 45
IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions
Anton Shkundin, Angelos Halaris
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 488-488
Open Access | Times Cited: 7
Treatment-Resistant Depression in Poland—Epidemiology and Treatment
Piotr Gałecki, Jerzy Samochowiec, Magdalena Mikułowska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 480-480
Open Access | Times Cited: 25
Neuropharmacology of Organoselenium Compounds in Mental Disorders and Degenerative Diseases
Paloma T. Birmann, Angela Maria Casaril, Laura Abenante, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 21, pp. 2357-2395
Closed Access | Times Cited: 23
Adaptogenic property of Asparagus racemosus: Future trends and prospects
Neha Singh, Meenakshi Garg, Priyanka Prajapati, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e14932-e14932
Open Access | Times Cited: 14
Hormonal and inflammatory signatures of different mood episodes in bipolar disorder: a large-scale clinical study
Nan Lyu, Qian Zhao, Bingbing Fu, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review
Matteo Di Vincenzo, Vassilis Martiadis, Bianca Della Rocca, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex
Maria Antonietta De Luca, Antonina Luca, A. Messina, et al.
Journal of Affective Disorders (2025)
Closed Access
New perspectives on galectin in major depressive disorder treatment
Laura Cabral Peixoto, Michelle Melgarejo da Rosa
Biochemical Pharmacology (2025) Vol. 233, pp. 116786-116786
Closed Access
Differences Between Adolescent Depression and Healthy Controls in Biomarkers Associated With Immune or Inflammatory Processes: A Systematic Review and Meta-Analysis
Jiao Li, Yan Zhang, Ning Yang, et al.
Psychiatry Investigation (2025) Vol. 22, Iss. 2, pp. 119-129
Closed Access
Targeting TNIP1 as a new therapeutic avenue for major depressive disorder
Yi-Yung Hung, Ching‐Chou Tsai, Chien-Te Lee, et al.
Brain Behavior and Immunity (2025) Vol. 126, pp. 214-224
Open Access
Can Vıtamın D Reduce the Need for SSRI by Modulatıng Serotonın Synthesıs?: A Revıew of Recent Lıterature
Zekiye Zeynep Bostan, Mustafa Bulut, Makbule Gezmen Karadağ
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Open Access
Assessment of complement cascade components in patients with major depressive disorder
Brandi Quintanilla, Dede Greenstein, Ashutosh Tripathi, et al.
Brain Behavior and Immunity (2025)
Closed Access
Vitamin D, B9, and B12 Deficiencies as Key Drivers of Clinical Severity and Metabolic Comorbidities in Major Psychiatric Disorders
Mélanie Faugère, Éloïse Maakaron, Vincent Achour, et al.
Nutrients (2025) Vol. 17, Iss. 7, pp. 1167-1167
Open Access
MTHFR Gene Polymorphisms: A Single Gene with Wide-Ranging Clinical Implications—A Review
Antoni F. Araszkiewicz, Krzysztof Jańczak, Paweł Wójcik, et al.
Genes (2025) Vol. 16, Iss. 4, pp. 441-441
Open Access
Biology of cyclooxygenase-2: An application in depression therapeutics
Ying He, Yuanshan Han, Xiaolin Liao, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 21
Fenugreek and Its Effects on Muscle Performance: A Systematic Review
Waleed Albaker
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 427-427
Open Access | Times Cited: 12
Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
Aleksander Kwaśny, Adam Włodarczyk, Damian Ogonowski, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 568-568
Open Access | Times Cited: 12
Treatment-Resistant Depression in Real-World Clinical Practice: A Systematic Literature Review of Data from 2012 to 2022
Albino J. Oliveira‐Maia, Ania Bobrowska, Éric Constant, et al.
Advances in Therapy (2023) Vol. 41, Iss. 1, pp. 34-64
Open Access | Times Cited: 11
Benefits and risks of esketamine nasal spray continuation in treatment-resistant depression
Maxwell Zachary Price, Richard L. Price
Biomarkers in Neuropsychiatry (2024) Vol. 11, pp. 100104-100104
Open Access | Times Cited: 4
Residual insomnia in major depressive disorder: a systematic review
Aleksander Kwaśny, Adam Włodarczyk, Alicja Dywel, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Interpreting the Mechanism of Active Ingredients in Polygonati Rhizoma in Treating Depression by Combining Systemic Pharmacology and In Vitro Experiments
Xin Wei, Dan Wang, Jiajia Liu, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1167-1167
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top